The Valley Desk

ArticleiSciencePublished

Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name University of Pennsylvania, The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
iScience
Published
Subject terms
Cancer; Therapeutics
PubMed ID
41704766
PubMed Central ID
PMC12907876
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal